Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001434316-14-000001
Filing Date
2014-03-18
Accepted
2014-03-18 12:16:19
Documents
1
Period of Report
2014-03-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1457
  Complete submission text file 0001434316-14-000001.txt   2719
Mailing Address
Business Address
EPSTEIN ROBERT S (Reporting) CIK: 0001252004 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36076 | Film No.: 14700037

Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Issuer) CIK: 0001434316 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2836 Biological Products, (No Diagnostic Substances)